Ignis obtains rights to develop and commercialize NeuroSigma’s FDA-approved Monarch eTNS System in China Initial launch of Generation 1.0...

LOS ANGELES, Jan. 11, 2022 (GLOBE NEWSWIRE) - NeuroSigma, Inc., a bioelectronic medical device company, today announced the promotion...

Transaction follows the June 2021 announcement of a strategic digital health partnership between NeuroSigma and KT Significant investment...